Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Alarming arbitrariness in EU prescription and reimbursement criteria for anti-dementia drugs.

× No keyword cloud information.

5 in total

1. Alzheimer disease: Perceived efficacy of antidementia drug treatment.

Authors: Kevina McAvinchey; Alistair Burns
Journal: Nat Rev Neurol Date: 2009-06 Impact factor: 42.937

2. Concurrent use of anticholinergic drugs and cholinesterase inhibitors: register-based study of over 700,000 elderly patients.

Authors: Kristina Johnell; Johan Fastbom
Journal: Drugs Aging Date: 2008 Impact factor: 3.923

3. A 2-year prospective cohort study of antidementia drug non-persistency in mild-to-moderate Alzheimer's disease in Europe : predictors of discontinuation and switch in the ICTUS study.

Authors: Virginie Gardette; Maryse Lapeyre-Mestre; Antoine Piau; Adeline Gallini; Christelle Cantet; Jean-Louis Montastruc; Bruno Vellas; Sandrine Andrieu
Journal: CNS Drugs Date: 2014-02 Impact factor: 5.749

4. Racial and Ethnic Differences in Initiation and Discontinuation of Antidementia Drugs by Medicare Beneficiaries.

Authors: Carolyn T Thorpe; Nicole R Fowler; Katherine Harrigan; Xinhua Zhao; Yihuang Kang; Joseph T Hanlon; Walid F Gellad; Loren J Schleiden; Joshua M Thorpe
Journal: J Am Geriatr Soc Date: 2016-08-22 Impact factor: 5.562

5. The impact of Medicare prescription drug coverage on the use of antidementia drugs.

Authors: Nicole R Fowler; Yi-Fan Chen; Christiana A Thurton; Aiju Men; Eric G Rodriguez; Julie M Donohue
Journal: BMC Geriatr Date: 2013-04-27 Impact factor: 3.921

5 in total